EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Rating of “Buy” from Analysts
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been assigned a consensus recommendation of “Buy” from the nine analysts that are currently covering the stock, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokerages that have updated their coverage on the stock […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been assigned a consensus recommendation of “Buy” from the nine analysts that are currently covering the stock, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokerages that have updated their coverage on the stock […]
